nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CYP2C9—Gefitinib—lung cancer	0.0552	0.0876	CbGbCtD
Rimonabant—CYP2C9—Teniposide—lung cancer	0.0535	0.085	CbGbCtD
Rimonabant—CYP2D6—Gefitinib—lung cancer	0.0505	0.0801	CbGbCtD
Rimonabant—CYP2D6—Vinorelbine—lung cancer	0.0389	0.0617	CbGbCtD
Rimonabant—CYP1A2—Erlotinib—lung cancer	0.0362	0.0575	CbGbCtD
Rimonabant—CYP3A4—Topotecan—lung cancer	0.0351	0.0557	CbGbCtD
Rimonabant—CYP3A4—Gefitinib—lung cancer	0.0321	0.0509	CbGbCtD
Rimonabant—CYP3A4—Teniposide—lung cancer	0.0311	0.0494	CbGbCtD
Rimonabant—CYP2C9—Paclitaxel—lung cancer	0.0299	0.0474	CbGbCtD
Rimonabant—CYP2D6—Erlotinib—lung cancer	0.0298	0.0474	CbGbCtD
Rimonabant—CYP1A2—Etoposide—lung cancer	0.0262	0.0416	CbGbCtD
Rimonabant—CYP3A4—Vinorelbine—lung cancer	0.0247	0.0392	CbGbCtD
Rimonabant—CYP2C9—Cisplatin—lung cancer	0.024	0.0381	CbGbCtD
Rimonabant—CYP2D6—Vinblastine—lung cancer	0.024	0.038	CbGbCtD
Rimonabant—CYP3A4—Crizotinib—lung cancer	0.0197	0.0312	CbGbCtD
Rimonabant—CYP3A4—Erlotinib—lung cancer	0.019	0.0301	CbGbCtD
Rimonabant—CYP3A4—Paclitaxel—lung cancer	0.0174	0.0276	CbGbCtD
Rimonabant—CYP3A4—Irinotecan—lung cancer	0.0171	0.0272	CbGbCtD
Rimonabant—CYP3A4—Vinblastine—lung cancer	0.0152	0.0242	CbGbCtD
Rimonabant—CYP2D6—Doxorubicin—lung cancer	0.0147	0.0234	CbGbCtD
Rimonabant—CYP3A4—Etoposide—lung cancer	0.0137	0.0218	CbGbCtD
Rimonabant—CYP3A4—Docetaxel—lung cancer	0.0126	0.0199	CbGbCtD
Rimonabant—CYP3A4—Doxorubicin—lung cancer	0.00936	0.0149	CbGbCtD
Rimonabant—Asthenia—Topotecan—lung cancer	0.000379	0.00174	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000376	0.00173	CcSEcCtD
Rimonabant—Asthenia—Erlotinib—lung cancer	0.000375	0.00172	CcSEcCtD
Rimonabant—Mental disorder—Paclitaxel—lung cancer	0.000374	0.00172	CcSEcCtD
Rimonabant—Pruritus—Topotecan—lung cancer	0.000373	0.00172	CcSEcCtD
Rimonabant—Malnutrition—Paclitaxel—lung cancer	0.000372	0.00171	CcSEcCtD
Rimonabant—Diarrhoea—Vinblastine—lung cancer	0.000372	0.00171	CcSEcCtD
Rimonabant—Infection—Irinotecan—lung cancer	0.00037	0.0017	CcSEcCtD
Rimonabant—Pruritus—Erlotinib—lung cancer	0.000369	0.0017	CcSEcCtD
Rimonabant—Gastrointestinal pain—Vinorelbine—lung cancer	0.000369	0.0017	CcSEcCtD
Rimonabant—Nervous system disorder—Irinotecan—lung cancer	0.000365	0.00168	CcSEcCtD
Rimonabant—Tension—Paclitaxel—lung cancer	0.000365	0.00168	CcSEcCtD
Rimonabant—Muscle spasms—Etoposide—lung cancer	0.000365	0.00168	CcSEcCtD
Rimonabant—Nervousness—Paclitaxel—lung cancer	0.000361	0.00166	CcSEcCtD
Rimonabant—Diarrhoea—Topotecan—lung cancer	0.000361	0.00166	CcSEcCtD
Rimonabant—Hypoaesthesia—Docetaxel—lung cancer	0.00036	0.00166	CcSEcCtD
Rimonabant—Infection—Gemcitabine—lung cancer	0.00036	0.00166	CcSEcCtD
Rimonabant—Irritability—Methotrexate—lung cancer	0.00036	0.00166	CcSEcCtD
Rimonabant—Hyperhidrosis—Irinotecan—lung cancer	0.00036	0.00166	CcSEcCtD
Rimonabant—Dizziness—Vinblastine—lung cancer	0.000359	0.00165	CcSEcCtD
Rimonabant—Convulsion—Cisplatin—lung cancer	0.000359	0.00165	CcSEcCtD
Rimonabant—Muscle spasms—Paclitaxel—lung cancer	0.000358	0.00164	CcSEcCtD
Rimonabant—Mood swings—Methotrexate—lung cancer	0.000358	0.00164	CcSEcCtD
Rimonabant—Diarrhoea—Erlotinib—lung cancer	0.000357	0.00164	CcSEcCtD
Rimonabant—Abdominal pain—Vinorelbine—lung cancer	0.000357	0.00164	CcSEcCtD
Rimonabant—Connective tissue disorder—Docetaxel—lung cancer	0.000356	0.00164	CcSEcCtD
Rimonabant—Nervous system disorder—Gemcitabine—lung cancer	0.000356	0.00164	CcSEcCtD
Rimonabant—Anorexia—Irinotecan—lung cancer	0.000355	0.00163	CcSEcCtD
Rimonabant—Skin disorder—Gemcitabine—lung cancer	0.000352	0.00162	CcSEcCtD
Rimonabant—Anxiety—Cisplatin—lung cancer	0.000351	0.00162	CcSEcCtD
Rimonabant—Hyperhidrosis—Gemcitabine—lung cancer	0.000351	0.00161	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.00035	0.00161	CcSEcCtD
Rimonabant—Hot flush—Doxorubicin—lung cancer	0.000349	0.00161	CcSEcCtD
Rimonabant—Dizziness—Topotecan—lung cancer	0.000349	0.0016	CcSEcCtD
Rimonabant—Tremor—Paclitaxel—lung cancer	0.000349	0.0016	CcSEcCtD
Rimonabant—Menopausal symptoms—Doxorubicin—lung cancer	0.000346	0.00159	CcSEcCtD
Rimonabant—Anorexia—Gemcitabine—lung cancer	0.000346	0.00159	CcSEcCtD
Rimonabant—Vomiting—Vinblastine—lung cancer	0.000345	0.00159	CcSEcCtD
Rimonabant—Dizziness—Erlotinib—lung cancer	0.000345	0.00159	CcSEcCtD
Rimonabant—Headache—Vinblastine—lung cancer	0.00034	0.00157	CcSEcCtD
Rimonabant—Insomnia—Irinotecan—lung cancer	0.000337	0.00155	CcSEcCtD
Rimonabant—Infection—Cisplatin—lung cancer	0.000336	0.00154	CcSEcCtD
Rimonabant—Vomiting—Topotecan—lung cancer	0.000336	0.00154	CcSEcCtD
Rimonabant—Hypoglycaemia—Doxorubicin—lung cancer	0.000335	0.00154	CcSEcCtD
Rimonabant—Paraesthesia—Irinotecan—lung cancer	0.000334	0.00154	CcSEcCtD
Rimonabant—Lethargy—Doxorubicin—lung cancer	0.000334	0.00153	CcSEcCtD
Rimonabant—Rash—Topotecan—lung cancer	0.000333	0.00153	CcSEcCtD
Rimonabant—Dermatitis—Topotecan—lung cancer	0.000332	0.00153	CcSEcCtD
Rimonabant—Vomiting—Erlotinib—lung cancer	0.000332	0.00153	CcSEcCtD
Rimonabant—Nervous system disorder—Cisplatin—lung cancer	0.000332	0.00152	CcSEcCtD
Rimonabant—Headache—Topotecan—lung cancer	0.000331	0.00152	CcSEcCtD
Rimonabant—Rash—Erlotinib—lung cancer	0.000329	0.00151	CcSEcCtD
Rimonabant—Dermatitis—Erlotinib—lung cancer	0.000329	0.00151	CcSEcCtD
Rimonabant—Convulsion—Etoposide—lung cancer	0.000329	0.00151	CcSEcCtD
Rimonabant—Angiopathy—Docetaxel—lung cancer	0.000329	0.00151	CcSEcCtD
Rimonabant—Skin disorder—Cisplatin—lung cancer	0.000328	0.00151	CcSEcCtD
Rimonabant—Insomnia—Gemcitabine—lung cancer	0.000328	0.00151	CcSEcCtD
Rimonabant—Headache—Erlotinib—lung cancer	0.000327	0.0015	CcSEcCtD
Rimonabant—Hyperhidrosis—Cisplatin—lung cancer	0.000327	0.0015	CcSEcCtD
Rimonabant—Mediastinal disorder—Docetaxel—lung cancer	0.000327	0.0015	CcSEcCtD
Rimonabant—Paraesthesia—Gemcitabine—lung cancer	0.000326	0.0015	CcSEcCtD
Rimonabant—Asthenia—Vinorelbine—lung cancer	0.000324	0.00149	CcSEcCtD
Rimonabant—Decreased appetite—Irinotecan—lung cancer	0.000324	0.00149	CcSEcCtD
Rimonabant—Nausea—Vinblastine—lung cancer	0.000323	0.00148	CcSEcCtD
Rimonabant—Convulsion—Paclitaxel—lung cancer	0.000322	0.00148	CcSEcCtD
Rimonabant—Anorexia—Cisplatin—lung cancer	0.000322	0.00148	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Irinotecan—lung cancer	0.000321	0.00148	CcSEcCtD
Rimonabant—Fatigue—Irinotecan—lung cancer	0.000321	0.00148	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000321	0.00148	CcSEcCtD
Rimonabant—Pruritus—Vinorelbine—lung cancer	0.000319	0.00147	CcSEcCtD
Rimonabant—Mental disorder—Docetaxel—lung cancer	0.000317	0.00146	CcSEcCtD
Rimonabant—Anxiety—Paclitaxel—lung cancer	0.000316	0.00145	CcSEcCtD
Rimonabant—Malnutrition—Docetaxel—lung cancer	0.000315	0.00145	CcSEcCtD
Rimonabant—Decreased appetite—Gemcitabine—lung cancer	0.000315	0.00145	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000315	0.00145	CcSEcCtD
Rimonabant—Nausea—Topotecan—lung cancer	0.000313	0.00144	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000313	0.00144	CcSEcCtD
Rimonabant—Abdominal discomfort—Methotrexate—lung cancer	0.000313	0.00144	CcSEcCtD
Rimonabant—Fatigue—Gemcitabine—lung cancer	0.000313	0.00144	CcSEcCtD
Rimonabant—Nausea—Erlotinib—lung cancer	0.00031	0.00143	CcSEcCtD
Rimonabant—Dry mouth—Paclitaxel—lung cancer	0.00031	0.00142	CcSEcCtD
Rimonabant—Mood swings—Doxorubicin—lung cancer	0.00031	0.00142	CcSEcCtD
Rimonabant—Diarrhoea—Vinorelbine—lung cancer	0.000309	0.00142	CcSEcCtD
Rimonabant—Infection—Etoposide—lung cancer	0.000308	0.00141	CcSEcCtD
Rimonabant—Gastrointestinal pain—Irinotecan—lung cancer	0.000304	0.0014	CcSEcCtD
Rimonabant—Paraesthesia—Cisplatin—lung cancer	0.000304	0.0014	CcSEcCtD
Rimonabant—Muscle spasms—Docetaxel—lung cancer	0.000303	0.00139	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Methotrexate—lung cancer	0.000303	0.00139	CcSEcCtD
Rimonabant—Infection—Paclitaxel—lung cancer	0.000302	0.00139	CcSEcCtD
Rimonabant—Skin disorder—Etoposide—lung cancer	0.000301	0.00138	CcSEcCtD
Rimonabant—Hyperhidrosis—Etoposide—lung cancer	0.000299	0.00138	CcSEcCtD
Rimonabant—Dizziness—Vinorelbine—lung cancer	0.000299	0.00137	CcSEcCtD
Rimonabant—Nervous system disorder—Paclitaxel—lung cancer	0.000298	0.00137	CcSEcCtD
Rimonabant—Anorexia—Etoposide—lung cancer	0.000295	0.00136	CcSEcCtD
Rimonabant—Skin disorder—Paclitaxel—lung cancer	0.000295	0.00136	CcSEcCtD
Rimonabant—Abdominal pain—Irinotecan—lung cancer	0.000294	0.00135	CcSEcCtD
Rimonabant—Decreased appetite—Cisplatin—lung cancer	0.000294	0.00135	CcSEcCtD
Rimonabant—Hyperhidrosis—Paclitaxel—lung cancer	0.000294	0.00135	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Cisplatin—lung cancer	0.000292	0.00134	CcSEcCtD
Rimonabant—Infestation—Methotrexate—lung cancer	0.000291	0.00134	CcSEcCtD
Rimonabant—Infestation NOS—Methotrexate—lung cancer	0.000291	0.00134	CcSEcCtD
Rimonabant—Depression—Methotrexate—lung cancer	0.00029	0.00133	CcSEcCtD
Rimonabant—Anorexia—Paclitaxel—lung cancer	0.000289	0.00133	CcSEcCtD
Rimonabant—Vomiting—Vinorelbine—lung cancer	0.000287	0.00132	CcSEcCtD
Rimonabant—Rash—Vinorelbine—lung cancer	0.000285	0.00131	CcSEcCtD
Rimonabant—Dermatitis—Vinorelbine—lung cancer	0.000284	0.00131	CcSEcCtD
Rimonabant—Headache—Vinorelbine—lung cancer	0.000283	0.0013	CcSEcCtD
Rimonabant—Influenza—Doxorubicin—lung cancer	0.000282	0.0013	CcSEcCtD
Rimonabant—Paraesthesia—Etoposide—lung cancer	0.000278	0.00128	CcSEcCtD
Rimonabant—Insomnia—Paclitaxel—lung cancer	0.000275	0.00126	CcSEcCtD
Rimonabant—Convulsion—Docetaxel—lung cancer	0.000273	0.00126	CcSEcCtD
Rimonabant—Paraesthesia—Paclitaxel—lung cancer	0.000273	0.00125	CcSEcCtD
Rimonabant—Decreased appetite—Etoposide—lung cancer	0.000269	0.00124	CcSEcCtD
Rimonabant—Nausea—Vinorelbine—lung cancer	0.000268	0.00123	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Etoposide—lung cancer	0.000267	0.00123	CcSEcCtD
Rimonabant—Asthenia—Irinotecan—lung cancer	0.000267	0.00123	CcSEcCtD
Rimonabant—Fatigue—Etoposide—lung cancer	0.000267	0.00123	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000267	0.00123	CcSEcCtD
Rimonabant—Decreased appetite—Paclitaxel—lung cancer	0.000264	0.00121	CcSEcCtD
Rimonabant—Dry mouth—Docetaxel—lung cancer	0.000263	0.00121	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000263	0.00121	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000262	0.00121	CcSEcCtD
Rimonabant—Fatigue—Paclitaxel—lung cancer	0.000262	0.0012	CcSEcCtD
Rimonabant—Asthenia—Gemcitabine—lung cancer	0.00026	0.0012	CcSEcCtD
Rimonabant—Pruritus—Gemcitabine—lung cancer	0.000257	0.00118	CcSEcCtD
Rimonabant—Infection—Docetaxel—lung cancer	0.000256	0.00118	CcSEcCtD
Rimonabant—Diarrhoea—Irinotecan—lung cancer	0.000255	0.00117	CcSEcCtD
Rimonabant—Gastrointestinal pain—Etoposide—lung cancer	0.000253	0.00116	CcSEcCtD
Rimonabant—Nervous system disorder—Docetaxel—lung cancer	0.000252	0.00116	CcSEcCtD
Rimonabant—Infestation NOS—Doxorubicin—lung cancer	0.000252	0.00116	CcSEcCtD
Rimonabant—Infestation—Doxorubicin—lung cancer	0.000252	0.00116	CcSEcCtD
Rimonabant—Skin disorder—Docetaxel—lung cancer	0.00025	0.00115	CcSEcCtD
Rimonabant—Gastrointestinal pain—Paclitaxel—lung cancer	0.000248	0.00114	CcSEcCtD
Rimonabant—Diarrhoea—Gemcitabine—lung cancer	0.000248	0.00114	CcSEcCtD
Rimonabant—Dizziness—Irinotecan—lung cancer	0.000246	0.00113	CcSEcCtD
Rimonabant—Anorexia—Docetaxel—lung cancer	0.000245	0.00113	CcSEcCtD
Rimonabant—Abdominal pain—Etoposide—lung cancer	0.000245	0.00113	CcSEcCtD
Rimonabant—Asthenia—Cisplatin—lung cancer	0.000243	0.00112	CcSEcCtD
Rimonabant—Abdominal pain—Paclitaxel—lung cancer	0.00024	0.0011	CcSEcCtD
Rimonabant—Angiopathy—Methotrexate—lung cancer	0.000237	0.00109	CcSEcCtD
Rimonabant—Vomiting—Irinotecan—lung cancer	0.000237	0.00109	CcSEcCtD
Rimonabant—Sinusitis—Doxorubicin—lung cancer	0.000236	0.00109	CcSEcCtD
Rimonabant—Mediastinal disorder—Methotrexate—lung cancer	0.000235	0.00108	CcSEcCtD
Rimonabant—Rash—Irinotecan—lung cancer	0.000235	0.00108	CcSEcCtD
Rimonabant—Dermatitis—Irinotecan—lung cancer	0.000235	0.00108	CcSEcCtD
Rimonabant—Headache—Irinotecan—lung cancer	0.000233	0.00107	CcSEcCtD
Rimonabant—Insomnia—Docetaxel—lung cancer	0.000233	0.00107	CcSEcCtD
Rimonabant—Diarrhoea—Cisplatin—lung cancer	0.000231	0.00106	CcSEcCtD
Rimonabant—Paraesthesia—Docetaxel—lung cancer	0.000231	0.00106	CcSEcCtD
Rimonabant—Vomiting—Gemcitabine—lung cancer	0.000231	0.00106	CcSEcCtD
Rimonabant—Mental disorder—Methotrexate—lung cancer	0.000229	0.00105	CcSEcCtD
Rimonabant—Rash—Gemcitabine—lung cancer	0.000229	0.00105	CcSEcCtD
Rimonabant—Dermatitis—Gemcitabine—lung cancer	0.000228	0.00105	CcSEcCtD
Rimonabant—Malnutrition—Methotrexate—lung cancer	0.000227	0.00105	CcSEcCtD
Rimonabant—Headache—Gemcitabine—lung cancer	0.000227	0.00104	CcSEcCtD
Rimonabant—Hypoaesthesia—Doxorubicin—lung cancer	0.000225	0.00103	CcSEcCtD
Rimonabant—Decreased appetite—Docetaxel—lung cancer	0.000224	0.00103	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Docetaxel—lung cancer	0.000222	0.00102	CcSEcCtD
Rimonabant—Asthenia—Etoposide—lung cancer	0.000222	0.00102	CcSEcCtD
Rimonabant—Connective tissue disorder—Doxorubicin—lung cancer	0.000222	0.00102	CcSEcCtD
Rimonabant—Fatigue—Docetaxel—lung cancer	0.000222	0.00102	CcSEcCtD
Rimonabant—Nausea—Irinotecan—lung cancer	0.000221	0.00102	CcSEcCtD
Rimonabant—Pruritus—Etoposide—lung cancer	0.000219	0.00101	CcSEcCtD
Rimonabant—Asthenia—Paclitaxel—lung cancer	0.000218	0.001	CcSEcCtD
Rimonabant—Nausea—Gemcitabine—lung cancer	0.000215	0.000991	CcSEcCtD
Rimonabant—Vomiting—Cisplatin—lung cancer	0.000215	0.000988	CcSEcCtD
Rimonabant—Pruritus—Paclitaxel—lung cancer	0.000215	0.000988	CcSEcCtD
Rimonabant—Rash—Cisplatin—lung cancer	0.000213	0.00098	CcSEcCtD
Rimonabant—Dermatitis—Cisplatin—lung cancer	0.000213	0.000979	CcSEcCtD
Rimonabant—Diarrhoea—Etoposide—lung cancer	0.000212	0.000974	CcSEcCtD
Rimonabant—Gastrointestinal pain—Docetaxel—lung cancer	0.00021	0.000968	CcSEcCtD
Rimonabant—Diarrhoea—Paclitaxel—lung cancer	0.000208	0.000955	CcSEcCtD
Rimonabant—Angiopathy—Doxorubicin—lung cancer	0.000205	0.000943	CcSEcCtD
Rimonabant—Dizziness—Etoposide—lung cancer	0.000205	0.000942	CcSEcCtD
Rimonabant—Mediastinal disorder—Doxorubicin—lung cancer	0.000204	0.000937	CcSEcCtD
Rimonabant—Abdominal pain—Docetaxel—lung cancer	0.000203	0.000936	CcSEcCtD
Rimonabant—Dizziness—Paclitaxel—lung cancer	0.000201	0.000923	CcSEcCtD
Rimonabant—Nausea—Cisplatin—lung cancer	0.000201	0.000923	CcSEcCtD
Rimonabant—Mental disorder—Doxorubicin—lung cancer	0.000198	0.000911	CcSEcCtD
Rimonabant—Convulsion—Methotrexate—lung cancer	0.000197	0.000906	CcSEcCtD
Rimonabant—Vomiting—Etoposide—lung cancer	0.000197	0.000906	CcSEcCtD
Rimonabant—Malnutrition—Doxorubicin—lung cancer	0.000197	0.000905	CcSEcCtD
Rimonabant—Rash—Etoposide—lung cancer	0.000195	0.000898	CcSEcCtD
Rimonabant—Dermatitis—Etoposide—lung cancer	0.000195	0.000897	CcSEcCtD
Rimonabant—Headache—Etoposide—lung cancer	0.000194	0.000892	CcSEcCtD
Rimonabant—Tension—Doxorubicin—lung cancer	0.000193	0.000888	CcSEcCtD
Rimonabant—Vomiting—Paclitaxel—lung cancer	0.000193	0.000888	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000192	0.000884	CcSEcCtD
Rimonabant—Rash—Paclitaxel—lung cancer	0.000191	0.00088	CcSEcCtD
Rimonabant—Dermatitis—Paclitaxel—lung cancer	0.000191	0.00088	CcSEcCtD
Rimonabant—Nervousness—Doxorubicin—lung cancer	0.000191	0.000879	CcSEcCtD
Rimonabant—Headache—Paclitaxel—lung cancer	0.00019	0.000875	CcSEcCtD
Rimonabant—Muscle spasms—Doxorubicin—lung cancer	0.000189	0.00087	CcSEcCtD
Rimonabant—Asthenia—Docetaxel—lung cancer	0.000185	0.000849	CcSEcCtD
Rimonabant—Infection—Methotrexate—lung cancer	0.000184	0.000847	CcSEcCtD
Rimonabant—Nausea—Etoposide—lung cancer	0.000184	0.000846	CcSEcCtD
Rimonabant—Pruritus—Docetaxel—lung cancer	0.000182	0.000837	CcSEcCtD
Rimonabant—Nervous system disorder—Methotrexate—lung cancer	0.000182	0.000837	CcSEcCtD
Rimonabant—Nausea—Paclitaxel—lung cancer	0.00018	0.000829	CcSEcCtD
Rimonabant—Skin disorder—Methotrexate—lung cancer	0.00018	0.000829	CcSEcCtD
Rimonabant—Hyperhidrosis—Methotrexate—lung cancer	0.000179	0.000825	CcSEcCtD
Rimonabant—Anorexia—Methotrexate—lung cancer	0.000177	0.000813	CcSEcCtD
Rimonabant—Diarrhoea—Docetaxel—lung cancer	0.000176	0.00081	CcSEcCtD
Rimonabant—Convulsion—Doxorubicin—lung cancer	0.000171	0.000784	CcSEcCtD
Rimonabant—Dizziness—Docetaxel—lung cancer	0.00017	0.000783	CcSEcCtD
Rimonabant—Insomnia—Methotrexate—lung cancer	0.000168	0.000772	CcSEcCtD
Rimonabant—Anxiety—Doxorubicin—lung cancer	0.000167	0.000768	CcSEcCtD
Rimonabant—Paraesthesia—Methotrexate—lung cancer	0.000167	0.000766	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000166	0.000765	CcSEcCtD
Rimonabant—Dry mouth—Doxorubicin—lung cancer	0.000164	0.000754	CcSEcCtD
Rimonabant—Vomiting—Docetaxel—lung cancer	0.000164	0.000753	CcSEcCtD
Rimonabant—Rash—Docetaxel—lung cancer	0.000162	0.000746	CcSEcCtD
Rimonabant—Dermatitis—Docetaxel—lung cancer	0.000162	0.000746	CcSEcCtD
Rimonabant—Decreased appetite—Methotrexate—lung cancer	0.000161	0.000742	CcSEcCtD
Rimonabant—Headache—Docetaxel—lung cancer	0.000161	0.000741	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Methotrexate—lung cancer	0.00016	0.000736	CcSEcCtD
Rimonabant—Fatigue—Methotrexate—lung cancer	0.00016	0.000735	CcSEcCtD
Rimonabant—Infection—Doxorubicin—lung cancer	0.00016	0.000734	CcSEcCtD
Rimonabant—Nervous system disorder—Doxorubicin—lung cancer	0.000158	0.000724	CcSEcCtD
Rimonabant—Skin disorder—Doxorubicin—lung cancer	0.000156	0.000717	CcSEcCtD
Rimonabant—Hyperhidrosis—Doxorubicin—lung cancer	0.000155	0.000714	CcSEcCtD
Rimonabant—Anorexia—Doxorubicin—lung cancer	0.000153	0.000704	CcSEcCtD
Rimonabant—Nausea—Docetaxel—lung cancer	0.000153	0.000703	CcSEcCtD
Rimonabant—Gastrointestinal pain—Methotrexate—lung cancer	0.000152	0.000698	CcSEcCtD
Rimonabant—Abdominal pain—Methotrexate—lung cancer	0.000147	0.000674	CcSEcCtD
Rimonabant—Insomnia—Doxorubicin—lung cancer	0.000145	0.000668	CcSEcCtD
Rimonabant—Paraesthesia—Doxorubicin—lung cancer	0.000144	0.000663	CcSEcCtD
Rimonabant—Decreased appetite—Doxorubicin—lung cancer	0.00014	0.000642	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000139	0.000638	CcSEcCtD
Rimonabant—Fatigue—Doxorubicin—lung cancer	0.000138	0.000637	CcSEcCtD
Rimonabant—Asthenia—Methotrexate—lung cancer	0.000133	0.000612	CcSEcCtD
Rimonabant—Gastrointestinal pain—Doxorubicin—lung cancer	0.000131	0.000604	CcSEcCtD
Rimonabant—Pruritus—Methotrexate—lung cancer	0.000131	0.000604	CcSEcCtD
Rimonabant—Abdominal pain—Doxorubicin—lung cancer	0.000127	0.000584	CcSEcCtD
Rimonabant—Diarrhoea—Methotrexate—lung cancer	0.000127	0.000584	CcSEcCtD
Rimonabant—Dizziness—Methotrexate—lung cancer	0.000123	0.000564	CcSEcCtD
Rimonabant—Vomiting—Methotrexate—lung cancer	0.000118	0.000542	CcSEcCtD
Rimonabant—Rash—Methotrexate—lung cancer	0.000117	0.000538	CcSEcCtD
Rimonabant—Dermatitis—Methotrexate—lung cancer	0.000117	0.000537	CcSEcCtD
Rimonabant—Headache—Methotrexate—lung cancer	0.000116	0.000534	CcSEcCtD
Rimonabant—Asthenia—Doxorubicin—lung cancer	0.000115	0.00053	CcSEcCtD
Rimonabant—Pruritus—Doxorubicin—lung cancer	0.000114	0.000523	CcSEcCtD
Rimonabant—Nausea—Methotrexate—lung cancer	0.00011	0.000507	CcSEcCtD
Rimonabant—Diarrhoea—Doxorubicin—lung cancer	0.00011	0.000505	CcSEcCtD
Rimonabant—Dizziness—Doxorubicin—lung cancer	0.000106	0.000488	CcSEcCtD
Rimonabant—Vomiting—Doxorubicin—lung cancer	0.000102	0.00047	CcSEcCtD
Rimonabant—Rash—Doxorubicin—lung cancer	0.000101	0.000466	CcSEcCtD
Rimonabant—Dermatitis—Doxorubicin—lung cancer	0.000101	0.000465	CcSEcCtD
Rimonabant—Headache—Doxorubicin—lung cancer	0.000101	0.000463	CcSEcCtD
Rimonabant—Nausea—Doxorubicin—lung cancer	9.54e-05	0.000439	CcSEcCtD
Rimonabant—CYP3A4—Metabolism—ATP5H—lung cancer	3.18e-05	0.000208	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—AKT1—lung cancer	3.18e-05	0.000208	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—POMC—lung cancer	3.17e-05	0.000208	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CASP3—lung cancer	3.15e-05	0.000206	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL2—lung cancer	3.15e-05	0.000206	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP2A7—lung cancer	3.14e-05	0.000205	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MYC—lung cancer	3.13e-05	0.000205	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—IL6—lung cancer	3.13e-05	0.000205	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CKB—lung cancer	3.12e-05	0.000205	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP2A7—lung cancer	3.11e-05	0.000204	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SDC4—lung cancer	3.07e-05	0.000201	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCND1—lung cancer	3.07e-05	0.000201	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—EGFR—lung cancer	3.07e-05	0.000201	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—JUN—lung cancer	3.06e-05	0.0002	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SDC4—lung cancer	3.04e-05	0.000199	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MMP9—lung cancer	2.98e-05	0.000195	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CDKN1A—lung cancer	2.97e-05	0.000194	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PTEN—lung cancer	2.96e-05	0.000194	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CNDP2—lung cancer	2.94e-05	0.000192	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTM2—lung cancer	2.94e-05	0.000192	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—KRAS—lung cancer	2.9e-05	0.00019	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—AKT1—lung cancer	2.89e-05	0.000189	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—MTMR3—lung cancer	2.86e-05	0.000187	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PLBD1—lung cancer	2.84e-05	0.000186	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—EP300—lung cancer	2.82e-05	0.000185	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—RRM1—lung cancer	2.79e-05	0.000183	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTA3—lung cancer	2.79e-05	0.000183	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PGAM1—lung cancer	2.78e-05	0.000182	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—RRM1—lung cancer	2.77e-05	0.000181	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTA3—lung cancer	2.77e-05	0.000181	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—SRC—lung cancer	2.74e-05	0.00018	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—VEGFA—lung cancer	2.67e-05	0.000175	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PIK3CA—lung cancer	2.66e-05	0.000174	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP2A7—lung cancer	2.66e-05	0.000174	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—STAT3—lung cancer	2.65e-05	0.000173	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NRAS—lung cancer	2.64e-05	0.000173	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—B4GALT5—lung cancer	2.63e-05	0.000172	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—B4GALT5—lung cancer	2.6e-05	0.000171	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SDC4—lung cancer	2.6e-05	0.00017	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HSD17B10—lung cancer	2.59e-05	0.00017	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TP53—lung cancer	2.57e-05	0.000169	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTA4—lung cancer	2.56e-05	0.000167	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTA4—lung cancer	2.53e-05	0.000166	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MAPK3—lung cancer	2.53e-05	0.000166	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTA2—lung cancer	2.49e-05	0.000163	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.48e-05	0.000162	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTA2—lung cancer	2.47e-05	0.000162	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HRAS—lung cancer	2.46e-05	0.000161	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MYC—lung cancer	2.46e-05	0.000161	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CKB—lung cancer	2.41e-05	0.000158	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—EGFR—lung cancer	2.41e-05	0.000158	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTA1—lung cancer	2.4e-05	0.000157	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTA1—lung cancer	2.38e-05	0.000156	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ABCC3—lung cancer	2.38e-05	0.000156	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—RRM1—lung cancer	2.37e-05	0.000155	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTA3—lung cancer	2.37e-05	0.000155	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IL6—lung cancer	2.36e-05	0.000154	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ABCC3—lung cancer	2.36e-05	0.000154	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—AKR1C1—lung cancer	2.3e-05	0.000151	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—AKR1C1—lung cancer	2.28e-05	0.000149	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—KRAS—lung cancer	2.27e-05	0.000149	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTM2—lung cancer	2.27e-05	0.000148	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CNDP2—lung cancer	2.27e-05	0.000148	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—UGT1A1—lung cancer	2.23e-05	0.000146	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—B4GALT5—lung cancer	2.23e-05	0.000146	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—UGT1A1—lung cancer	2.21e-05	0.000145	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—MTMR3—lung cancer	2.2e-05	0.000144	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—AKT1—lung cancer	2.17e-05	0.000142	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTA4—lung cancer	2.17e-05	0.000142	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GNG11—lung cancer	2.15e-05	0.000141	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PGAM1—lung cancer	2.15e-05	0.000141	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GNG11—lung cancer	2.14e-05	0.00014	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.12e-05	0.000139	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.12e-05	0.000139	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTA2—lung cancer	2.11e-05	0.000138	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PIK3CA—lung cancer	2.09e-05	0.000137	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ALDOA—lung cancer	2.05e-05	0.000134	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP2A7—lung cancer	2.05e-05	0.000134	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTA1—lung cancer	2.04e-05	0.000133	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ALDOA—lung cancer	2.03e-05	0.000133	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TP53—lung cancer	2.02e-05	0.000132	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ABCC3—lung cancer	2.01e-05	0.000132	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SDC4—lung cancer	2.01e-05	0.000131	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NCOA3—lung cancer	1.99e-05	0.00013	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NCOA3—lung cancer	1.97e-05	0.000129	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—AKR1C1—lung cancer	1.95e-05	0.000128	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.94e-05	0.000127	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ADCY1—lung cancer	1.94e-05	0.000127	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ABCG2—lung cancer	1.94e-05	0.000127	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HRAS—lung cancer	1.93e-05	0.000127	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ADCY1—lung cancer	1.92e-05	0.000126	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ABCG2—lung cancer	1.92e-05	0.000126	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—HPGDS—lung cancer	1.9e-05	0.000124	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ENO2—lung cancer	1.9e-05	0.000124	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—UGT1A1—lung cancer	1.89e-05	0.000124	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.89e-05	0.000124	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—HPGDS—lung cancer	1.88e-05	0.000123	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ENO2—lung cancer	1.88e-05	0.000123	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.87e-05	0.000123	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL6—lung cancer	1.85e-05	0.000121	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.85e-05	0.000121	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTT1—lung cancer	1.84e-05	0.000121	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—RRM1—lung cancer	1.83e-05	0.00012	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTA3—lung cancer	1.83e-05	0.00012	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTT1—lung cancer	1.83e-05	0.00012	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GNG11—lung cancer	1.82e-05	0.00012	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP2A6—lung cancer	1.82e-05	0.000119	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GCLC—lung cancer	1.82e-05	0.000119	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.82e-05	0.000119	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GCLC—lung cancer	1.81e-05	0.000118	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP2A6—lung cancer	1.81e-05	0.000118	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.8e-05	0.000118	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ALDOA—lung cancer	1.74e-05	0.000114	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ENO1—lung cancer	1.73e-05	0.000113	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—B4GALT5—lung cancer	1.72e-05	0.000113	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ENO1—lung cancer	1.71e-05	0.000112	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—AKT1—lung cancer	1.71e-05	0.000112	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.71e-05	0.000112	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NCOA3—lung cancer	1.69e-05	0.00011	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.68e-05	0.00011	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTA4—lung cancer	1.67e-05	0.000109	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.66e-05	0.000109	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ABCG2—lung cancer	1.64e-05	0.000107	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ADCY1—lung cancer	1.64e-05	0.000107	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTA2—lung cancer	1.63e-05	0.000107	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HPGDS—lung cancer	1.61e-05	0.000105	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ENO2—lung cancer	1.61e-05	0.000105	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PPP2R1B—lung cancer	1.6e-05	0.000105	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.58e-05	0.000103	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTA1—lung cancer	1.57e-05	0.000103	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTT1—lung cancer	1.56e-05	0.000102	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ABCC3—lung cancer	1.55e-05	0.000102	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP2E1—lung cancer	1.55e-05	0.000101	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP2A6—lung cancer	1.54e-05	0.000101	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GCLC—lung cancer	1.54e-05	0.000101	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.54e-05	0.000101	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP2E1—lung cancer	1.54e-05	0.000101	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NQO1—lung cancer	1.53e-05	0.0001	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NQO1—lung cancer	1.52e-05	9.94e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—AKR1C1—lung cancer	1.5e-05	9.85e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.49e-05	9.73e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.47e-05	9.65e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ENO1—lung cancer	1.46e-05	9.58e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—UGT1A1—lung cancer	1.46e-05	9.57e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.46e-05	9.54e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.44e-05	9.42e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GNG11—lung cancer	1.41e-05	9.22e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—STK11—lung cancer	1.38e-05	9.04e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—STK11—lung cancer	1.37e-05	8.96e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALDOA—lung cancer	1.34e-05	8.78e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP2E1—lung cancer	1.31e-05	8.59e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NCOA3—lung cancer	1.3e-05	8.53e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NQO1—lung cancer	1.3e-05	8.5e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.28e-05	8.41e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTP1—lung cancer	1.28e-05	8.36e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.27e-05	8.32e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ADCY1—lung cancer	1.27e-05	8.29e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ABCG2—lung cancer	1.27e-05	8.29e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTP1—lung cancer	1.27e-05	8.29e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.26e-05	8.24e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CAT—lung cancer	1.24e-05	8.14e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HPGDS—lung cancer	1.24e-05	8.13e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ENO2—lung cancer	1.24e-05	8.13e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.23e-05	8.08e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CAT—lung cancer	1.23e-05	8.07e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.22e-05	8.02e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ABCB1—lung cancer	1.21e-05	7.92e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTT1—lung cancer	1.2e-05	7.89e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ABCB1—lung cancer	1.2e-05	7.85e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP2A6—lung cancer	1.19e-05	7.8e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GCLC—lung cancer	1.19e-05	7.8e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—TYMS—lung cancer	1.19e-05	7.78e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—TYMS—lung cancer	1.18e-05	7.71e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTM1—lung cancer	1.17e-05	7.69e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—STK11—lung cancer	1.17e-05	7.66e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTM1—lung cancer	1.16e-05	7.62e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ENO1—lung cancer	1.13e-05	7.39e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP1A1—lung cancer	1.11e-05	7.29e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ERCC2—lung cancer	1.1e-05	7.23e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP1A1—lung cancer	1.1e-05	7.22e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.1e-05	7.19e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ERCC2—lung cancer	1.09e-05	7.16e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTP1—lung cancer	1.08e-05	7.09e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CAT—lung cancer	1.05e-05	6.89e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.05e-05	6.85e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ABCB1—lung cancer	1.02e-05	6.71e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP2E1—lung cancer	1.01e-05	6.63e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—TYMS—lung cancer	1.01e-05	6.59e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NQO1—lung cancer	1e-05	6.56e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTM1—lung cancer	9.94e-06	6.51e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—APOA1—lung cancer	9.54e-06	6.25e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—APOA1—lung cancer	9.46e-06	6.2e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP1A1—lung cancer	9.42e-06	6.17e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ERCC2—lung cancer	9.35e-06	6.12e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.06e-06	5.93e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—STK11—lung cancer	9.02e-06	5.91e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CG—lung cancer	8.71e-06	5.71e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CG—lung cancer	8.64e-06	5.66e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTP1—lung cancer	8.35e-06	5.47e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—POMC—lung cancer	8.29e-06	5.43e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—POMC—lung cancer	8.22e-06	5.39e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CAT—lung cancer	8.12e-06	5.32e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—APOA1—lung cancer	8.09e-06	5.3e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CREBBP—lung cancer	8.08e-06	5.29e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CREBBP—lung cancer	8.01e-06	5.25e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ABCB1—lung cancer	7.9e-06	5.18e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TYMS—lung cancer	7.76e-06	5.08e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.74e-06	5.07e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTM1—lung cancer	7.67e-06	5.02e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CD—lung cancer	7.66e-06	5.02e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CD—lung cancer	7.59e-06	4.97e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ALB—lung cancer	7.56e-06	4.95e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ALB—lung cancer	7.5e-06	4.91e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CG—lung cancer	7.38e-06	4.83e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP1A1—lung cancer	7.27e-06	4.76e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ERCC2—lung cancer	7.21e-06	4.72e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—POMC—lung cancer	7.03e-06	4.6e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CREBBP—lung cancer	6.84e-06	4.48e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CB—lung cancer	6.68e-06	4.37e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CB—lung cancer	6.62e-06	4.34e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTGS2—lung cancer	6.62e-06	4.33e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTGS2—lung cancer	6.56e-06	4.3e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CD—lung cancer	6.49e-06	4.25e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ALB—lung cancer	6.41e-06	4.2e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—APOA1—lung cancer	6.24e-06	4.09e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTEN—lung cancer	5.77e-06	3.78e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTEN—lung cancer	5.72e-06	3.75e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CG—lung cancer	5.7e-06	3.73e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CB—lung cancer	5.66e-06	3.7e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTGS2—lung cancer	5.6e-06	3.67e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—EP300—lung cancer	5.5e-06	3.6e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—EP300—lung cancer	5.45e-06	3.57e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—POMC—lung cancer	5.42e-06	3.55e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CREBBP—lung cancer	5.28e-06	3.46e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CD—lung cancer	5.01e-06	3.28e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALB—lung cancer	4.94e-06	3.24e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTEN—lung cancer	4.89e-06	3.2e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—EP300—lung cancer	4.66e-06	3.05e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CB—lung cancer	4.37e-06	2.86e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTGS2—lung cancer	4.33e-06	2.83e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CA—lung cancer	4.07e-06	2.67e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CA—lung cancer	4.04e-06	2.64e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTEN—lung cancer	3.77e-06	2.47e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—EP300—lung cancer	3.6e-06	2.36e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CA—lung cancer	3.45e-06	2.26e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—AKT1—lung cancer	3.33e-06	2.18e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—AKT1—lung cancer	3.3e-06	2.16e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—AKT1—lung cancer	2.82e-06	1.84e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CA—lung cancer	2.66e-06	1.74e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—AKT1—lung cancer	2.17e-06	1.42e-05	CbGpPWpGaD
